b12 injection with lidocaine 1% injectable -20 ml multiple-dose (NDC#31722-116-20 LOT#AS1 – Prepared Physician Lidocaine HCl 2%, 5 mL

Structurally, the active cation (C 10 H 11 N 2 + , MW 159.21) is a methylated quinolinium ring carrying a 5-amino substituent

Plan: measurable treatment goals, therapy plan, follow-up timeline Etiology workup: documented evaluation steps when appropriate Sample documentation statements that reduce denials Use direct, measurable language: Strength reduced across bilateral hip flexors and knee extensors with impaired sit-to-stand transfers

It activates hypothalamic POMC neurons to induce satiety and decrease food intake but does not affect energy expenditure

Failure to sequence correctly constitutes a coding error and may trigger a Correct Coding Initiative (CCI) edit

PMID 12082127